Arepalli, Sruthi
Wykoff, Charles C.
Abraham, Joseph R.
Lunasco, Leina
Yu, Hannah
Hu, Ming
Srivastava, Sunil K.
Reese, Jamie L.
Brown, David
Ehlers, Justis P. http://orcid.org/0000-0001-6763-7768
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (K23-EY022947-01A1)
Article History
Received: 8 November 2021
Revised: 14 August 2022
Accepted: 15 September 2022
First Online: 11 October 2022
Competing interests
: CCW has research support from the following: Adverum, Allergan, Apellis, Clearside, EyePoint, Genentech/Roch, Neurotech, Novartis, Opthea, Regeneron, Regenxbio, Samsung, Santen; is a consultant for the following: Alimera Sciences, Allegro, Allergan, Alynylam, Apellis, Bayer, Clearside, D.O.R.C., EyePoint, Genentech/Roche, Kodiak, Notal Vision, Novartis, ONL Therapeutics, PolyPhotonix, RecensMedical, Regeneron, Regenxbio, Santen; and is a speaker for Regeneron. SKS has research support from Regeneron, Allergan, and Gilead; is a consultant for Bausch and Lomb, Novartis, and Regeneron. DMB has research support from the following: Adverum, Allergan, Apellis, Clearside, Genentech/Roch, Novartis, Opthea, Regeneron, Regenxbio, Samsung, Santen; is a consultant for the following: Regeneron, Bayer, Senju, Allergan, Optos, Zeiss, Heidelberg, OHR, Biotime, Gemini, Genentech/Roche, Novartis, Apellis, Regenxbio, Chengdu Kanghong Biotechnology. JPE has research support from the following: Aerpio, Alcon, Thrombogenics/Oxurion, Regeneron, Genentech, Novartis, Allergan; is a consultant for the following: Aerpio, Alcon, Allegro, Allergan, Adverum, Genentech/Roche, Novartis, Thrombogenics/Oxurion, Leica, Zeiss, Regeneron, Stealth; and holds a patent with Leica. JRA, SA, LL, HJY, MH, JLR have no financial disclosures to report. The authors declare no competing interests.